Literature DB >> 19752232

Bacterial surface protein L binds and inactivates neutrophil proteins S100A8/A9.

Bo Akerström1, Lars Björck.   

Abstract

Finegoldia magna is an anaerobic bacterial species that is part of the normal human flora on all nonsterile body surfaces, but it is also a significant opportunistic pathogen causing a wide range of infections. Some isolates of F. magna that are more frequently associated with clinical infection express protein L, a surface protein containing multiple homologous domains (B1-B5) that bind Igs through interactions with Ig L chains. The present study shows that the N-terminal A domain of protein L binds S100A8/A9, antibacterial proteins present in large amounts in the cytoplasm of neutrophils, but also extracellularly in tissues during inflammation. As a result, protein L-expressing F. magna are protected against killing by S100A8/A9. Igs and S100A8/A9 were found to interact independently with protein L, demonstrating that this bacterial surface protein is capable of manipulating both adaptive and innate immune defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752232     DOI: 10.4049/jimmunol.0901487

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

2.  The B-cell superantigen Finegoldia magna protein L causes pulmonary inflammation by a mechanism dependent on MyD88 but not B cells or immunoglobulins.

Authors:  Amy L Anderson; Yi Zheng; Decheng Song; David Larosa; Nico Van Rooijen; Gerold Kierstein; Sonja Kierstein; Angela Haczku; Arnold I Levinson
Journal:  Inflamm Res       Date:  2012-01-17       Impact factor: 4.575

3.  MRP8/14 enhances corneal susceptibility to Pseudomonas aeruginosa Infection by amplifying inflammatory responses.

Authors:  Qiuchan Deng; Mingxia Sun; Kun Yang; Min Zhu; Kang Chen; Jin Yuan; Minhao Wu; Xi Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

4.  Antimicrobial action of calprotectin that does not involve metal withholding.

Authors:  Angelique N Besold; Edward M Culbertson; Lily Nam; Ryan P Hobbs; Alisa Boyko; C Noel Maxwell; Walter J Chazin; Adriana R Marques; Valeria C Culotta
Journal:  Metallomics       Date:  2018-12-12       Impact factor: 4.526

5.  Host-microbiome protein-protein interactions capture disease-relevant pathways.

Authors:  Hao Zhou; Juan Felipe Beltrán; Ilana Lauren Brito
Journal:  Genome Biol       Date:  2022-03-04       Impact factor: 13.583

6.  Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Authors:  Hannah Trøstrup; Christian Johann Lerche; Lars Christophersen; Peter Østrup Jensen; Niels Høiby; Claus Moser
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.